User profiles for J. BRAUN

Juergen Braun

- Verified email at elisabethgruppe.de - Cited by 79664

Jonathan Braun

- Verified email at cshs.org - Cited by 24837

Julian Braun

- Verified email at bih-charite.de - Cited by 2069

Ankylosing spondylitis

J Braun, J Sieper - The Lancet, 2007 - thelancet.com
Ankylosing spondylitis is a common inflammatory rheumatic disease that affects the axial
skeleton, causing characteristic inflammatory back pain, which can lead to structural and …

[HTML][HTML] Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases

…, D Shungin, Y Vázquez-Baeza, RA White III, J Braun… - Nature, 2019 - nature.com
Inflammatory bowel diseases, which include Crohn’s disease and ulcerative colitis, affect
several million individuals worldwide. Crohn’s disease and ulcerative colitis are complex …

2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis

J Braun, R van den Berg, X Baraliakos… - Annals of the …, 2011 - ard.bmj.com
This first update of the ASAS/EULAR recommendations on the management of ankylosing
spondylitis (AS) is based on the original paper, a systematic review of existing …

The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection

…, J Listing, N Akkoc, J Brandt, J Braun… - Annals of the …, 2009 - ard.bmj.com
Objective: To validate and refine two sets of candidate criteria for the classification/diagnosis
of axial spondyloarthritis (SpA). Methods: All Assessment of SpondyloArthritis international …

The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis

…, M Rudwaleit, X Baraliakos, J Brandt, J Braun… - Annals of the …, 2009 - ard.bmj.com
The field of spondyloarthritis (SpA) has experienced major progress in the last decade,
especially with regard to new treatments, earlier diagnosis, imaging technology and a better …

[HTML][HTML] SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19

J Braun, L Loyal, M Frentsch, D Wendisch, P Georg… - Nature, 2020 - nature.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused the rapidly
unfolding coronavirus disease 2019 (COVID-19) pandemic 1, 2. Clinical manifestations of …

Retinoic acid embryopathy

…, ND Agnish, PJ Benke, JT Braun… - … England Journal of …, 1985 - Mass Medical Soc
Retinoic acid, an analogue of vitamin A, is known to be teratogenic in laboratory animals
and has recently been implicated in a few clinical case reports. To study the human …

Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial

J Braun, J Brandt, J Listing, A Zink, R Alten, W Golder… - The Lancet, 2002 - thelancet.com
Background Treatment options for patients with ankylosing spondylitis are few. We aimed to
assess the effectiveness of infliximab, an antibody to tumour necrosis factor (TNF)-α, in …

2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis

…, P Sampaio-Barros, D Wiek, J Braun - Annals of the …, 2017 - ard.bmj.com
To update and integrate the recommendations for ankylosing spondylitis and the recommendations
for the use of tumour necrosis factor inhibitors (TNFi) in axial spondyloarthritis (axSpA…

[HTML][HTML] Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension

…, PJ Gheeraert, LH Missault, JJ Braun… - … England Journal of …, 2003 - Mass Medical Soc
Background It is uncertain whether ambulatory blood-pressure measurements recorded for
24 hours in patients with treated hypertension predict cardiovascular events independently of …